How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
Özden Gür Ali; Başak Topaler
| Year of publication: |
2011
|
|---|---|
| Authors: | Özden Gür Ali ; Topaler, Başak |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 12.2011, 6, p. 553-562
|
| Subject: | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs | Pharmaindustrie | Pharmaceutical industry | Arzneimittelmarkt | Pharmaceutical market |
| Extent: | graph. Darst. |
|---|---|
| Type of publication: | Article |
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10009376933